Cecilia R. Chambers
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.
Journal: Science advances
Published: March 12, 2025
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response.
Journal: Science advances
Published: July 03, 2024
BCRP drives intrinsic chemoresistance in chemotherapy-naïve breast cancer brain metastasis.
Journal: Science advances
Published: October 18, 2023
Cell-derived Matrix Assays to Assess Extracellular Matrix Architecture and Track Cell Movement.
Journal: Bio-protocol
Published: June 20, 2022
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status.
Journal: Science advances
Published: September 29, 2021
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.
Journal: Nature cancer
Published: September 28, 2021
Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
Journal: Molecular oncology
Published: February 01, 2021
CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer.
Journal: Trends in cancer
Published: June 24, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026